Cargando…
Allergen specific immunotherapy has no influence on standard chemistry and hematology laboratory parameters in clinical studies
BACKGROUND: A set of standard clinical chemistry and hematology parameters are usually measured during clinical studies. The major outcome of these standard tests is to control that the drug investigated does not lead to pathophysiological changes in respective organs or blood. In some cases based o...
Autores principales: | Häfner, Dietrich, Gödicke, Viola, Narkus, Annemie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064516/ https://www.ncbi.nlm.nih.gov/pubmed/24955235 http://dx.doi.org/10.1186/2045-7022-4-18 |
Ejemplares similares
-
The placebo effect in allergen-specific immunotherapy trials
por: Narkus, Annemie, et al.
Publicado: (2013) -
Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial
por: Klimek, Ludger, et al.
Publicado: (2015) -
Prospective validation of the “rhino conjunctivitis allergy-control-SCORE(©)” (RC-ACS(©))
por: Häfner, Dietrich, et al.
Publicado: (2012) -
Allergen-specific immunotherapy
por: Moote, William, et al.
Publicado: (2011) -
Allergen-specific immunotherapy
por: Moote, William, et al.
Publicado: (2018)